R&D News | pharmaphorum

News

Steve Davis, president and chief executive of Acadia Pharma

Acadia pulls trials of pimavanserin after schizophrenia fail

Acadia Pharma’s plan to develop pimavanserin as a treatment for additional indications is in disarray after the drug failed a phase 3 trial in schizophrenia.

News

AAD: Sanofi showcases data on possible Dupixent successor

Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2

News

AAD: J&J’s oral IL-23 drug shows durability in psoriasis

Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 have been shown to maintain skin clearance for up to a year, pointing to a durable ef

News

Boehringer licenses Sosei schizophrenia drugs in €755m deal

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activit

News

Justin Klee and Joshua Cohen, co-CEOs of Amylyx Pharma

Amylyx plummets as confirmatory trial of ALS drug fails

Shares in Amylyx have cratered after the company reported a confirmatory trial of its amyotrophic lateral sclerosis (ALS) therapy Relyvrio missed all its objectives, putti

News

MindMed gets FDA breakthrough tag for LSD in anxiety

In another inflection point for the psychedelic medicines category, Mind Medicine (MindMed) has claimed breakthrough status from the FDA for its LSD-based candidate MM120

Acadia pulls trials of pimavanserin after schizophrenia fail

AAD: Sanofi showcases data on possible Dupixent successor

AAD: J&J’s oral IL-23 drug shows durability in psoriasis

Boehringer licenses Sosei schizophrenia drugs in €755m deal

Amylyx plummets as confirmatory trial of ALS drug fails

MindMed gets FDA breakthrough tag for LSD in anxiety

Novo Nordisk preps filings for sickle cell drug etavopivat

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks